Citation

T. Tartaglione, T. Tartaglione, Ann C. Collier, Kent Opheim, F. G. Gianola, Jacqueline K. Benedetti, Lawrence Corey. Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection. Antimicrobial Agents and Chemotherapy. 1991. 35: 2225-31.

Citation

Walter T. Hughes, Wren Kennedy, Jerry L. Shenep, Patricia M. Flynn, Seth Hetherington, Glenda H. Fullen, Danny Lancaster, Daniel S. Stein, Steven Palte, Deborah Rosenbaum, San H.T. Liao, M. Robert Blum, Michael D. Rogers. Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men. Journal of Infectious Diseases. 1991. 163: 843-8.

Citation

Margaret A. Fischl, Raj B. Uttamchandani, Lionel Resnick, Ram Agarwal, Mary Ann Fletcher, Janie Reese, Lisa Dearmas, Jane Chidekel, Mary McCann, Mark Myers. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. Journal of Acquired Immune Deficiency Syndromes. 1991. 4: 1-10.

Citation

Susan E. Krown, Donna Niedzwiecki, R. B. Bhalla, Neal Flomenberg, Denise Bundow, D. Chapman. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS. Journal of Acquired Immune Deficiency Syndromes. 1991. 4: 871-80.

Citation

David H. Schwartz, Gail Skowron, Thomas C. Merigan. Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus. Journal of Acquired Immune Deficiency Syndromes. 1991. 4: 11-23.

Citation

Charles Rinaldo, Charles Rinaldo, Xiao-Li Huang, P. Piazza, John A. Armstrong, G. Rappocciolo, George J. Pazin, Deborah McMahon, Phalguni Gupta, Z. Fan, Zhi-Qiang Zhang. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients. Journal of Infectious Diseases. 1991. 164: 638-45.

Citation

Charles Flexner, Patricia Barditch-Crovo, David Kornhauser, Homayoon Farzadegan, Lynda Nerhood, Richard E. Chaisson, Kathleen M. Bell, Kevin Lorentsen, Craig Hendrix, Brent Gray Petty, Paul S. Lietman. Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection. Antimicrobial Agents and Chemotherapy. 1991. 35: 2544-50.

Citation

Kenneth A. Freedberg, AN Tosteson, Calvin J. Cohen, Deborah Jean Cotton. Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis. Journal of Acquired Immune Deficiency Syndromes. 1991. 4: 521-31.

Citation

Edward V. Morse, Patricia M. Simon-Morse, Mary Coburn, Newton E. Hyslop, Deborah L. Greenspan, Paul Michael Balson. Determinants of subject compliance within an experimental anti-HIV drug protocol. Social Science and Medicine. 1991. 32: 1161-7.